Repligen other research news

RGEN described a compound that blocks bFGF and VEGF, two initiators of angiogenesis. The small molecule blocks the

Read the full 180 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE